reports
Intra-Cellular Therapies Prices Public Offering of Common Stock
Intra-Cellular Therapies Prices Public Offering of Common Stock NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the pricing of its previously announced underwritten public offering of 6,849,316 shares of its common stock at a public offering price of $73.00 per share. All of the shares in the offering will be sold by Intra-Cellular Therapies, with gross proceeds to I...
- Valens Research
- Limartha Adhiputra
- Maskun Ramli
Moody's Ratings assigns Aa1 to City & County of San Francisco, CA's 20...
Moody's Ratings (Moody's) has assigned a Aa1 rating to the City and County of San Francisco, CA's $213.8 million Refunding Certificates of Participation, Series 2024-R1 (Multiple Capital Improvement Projects) (Tax Exempt). Moody's maintains a Aaa issuer rating for the city, as well as Aa1 and Aa2 ra...
Moody's Ratings affirms Azalea TopCo's B3 CFR, outlook changed to stab...
Moody's Ratings affirmed the B3 corporate family ratings ("CFR") and B3-PD Probability of Default ratings ("PDR") of Azalea TopCo, Inc. ("PG Forsta") Moody's Ratings concurrently assigned instrument level ratings of B3 to the company's new senior secured first lien credit facilities that includes a ...
Moody's Ratings upgrades Stormont-Vail HealthCare (KS) to A1; outlook ...
Moody's Ratings (Moody's) has upgraded Stormont-Vail HealthCare's (KS)(SVH) issuer rating to A1 from A2 and revised the outlook to stable from positive at the new rating level. Total debt outstanding was $181 million at fiscal yearend 2023 (September 30). The upgrade to the A1 reflects the expecte...
Moody's Ratings affirms Alvaria's Caa1 CFR and assigns ratings to Alva...
Moody's Ratings (Moody's) affirmed Atlas Purchaser, Inc.'s (Alvaria) Corporate Family Rating (CFR) of Caa1. Moody's Ratings affirmed and appended a limited default (/LD) designation to Alvaria's Caa1-PD Probability of Default Rating (PDR). Concurrently, Moody's Ratings assigned the following ratings...
Moody's Ratings assigns A2 UND/Aa1 ENH to Lakeview Community Schools, ...
Moody's Ratings (Moody's) assigned A2 underlying and Aa1 enhanced ratings to Lakeview Community Schools, MI's 2024 School Building and Site Bonds, Series II (General Obligation - Unlimited Tax), which have a proposed par amount of $15 million. Moody's maintains the district's A2 issuer rating and a...
Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO
Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is providing an update with respect to the expected timeline for filing its audited financial statements for the fiscal year ended November 30, 2023, the related management's discussion and analysis and certificates of its CEO and CFO (collectively, the "Required Documents") and its previously announced management cease trade order ("MCTO") issued by the Company's principal regulator, the Briti...
- Jonathan Koh
Moody's Ratings downgrades Cast & Crew's CFR to B3 from B2 due to weak...
Moody's Ratings ("Moody's") has downgraded Cast & Crew LLC's ("Cast & Crew') corporate family rating ("CFR") from B2 to B3 and its probability of default rating ("PDR") from B2-PD to B3-PD. Concurrently, Moody's has assigned B2 ratings to the company's $150 million senior secured 1st lien revolver (...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.